Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bluejay Diagnostics (BJDX) Cash from Financing Activities (2023)

Bluejay Diagnostics' Cash from Financing Activities history spans 1 years, with the latest figure at -$3050.0 for Q4 2023.

  • For Q4 2023, Cash from Financing Activities changed N/A year-over-year to -$3050.0; the TTM value through Dec 2023 reached $1.1 million, changed N/A, while the annual FY2024 figure was $10.2 million, 819.43% up from the prior year.
  • Cash from Financing Activities for Q4 2023 was -$3050.0 at Bluejay Diagnostics, down from $1.2 million in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $1.2 million in Q3 2023 and bottomed at -$58803.0 in Q1 2023.